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828-2 Factors Predictive of a Late Recurrence of Atrial 
Fibrillation After Segmental Pulmonary Vein Isolation
Joseph B. Morton, Edward W. Lipman, Albert C. Lin, Sean P. Tierney, Martin C. Burke, 
John J. Cai, Peter A. Santucci, David J. Wilber, Loyola University Medical Center, 
Maywood, IL
Introduction Elucidating factors predictive of a late recurrence of atrial fibrillation
(RecAF) occurring >1 month after segmental pulmonary vein isolation (SPVI) may allow
identification of patients suitable for an alternative catheter ablation strategy.
Methods 147pts with symptomatic, drug refractory paroxysmal or persistent AF (>30
days requiring cardioversion) were studied. All underwent 4-vessel, lasso guided, SPVI
using intracardiac echo imaging to ensure anatomically precise radiofrequency ablation
at the PV ostium. Pts undergoing redo PV isolation were excluded from the analysis.
Clinical follow-up included phone interviews and ambulatory EKG monitoring. Univariate
and multivariate (logistic regression) analysis was performed to assess 11 factors as pos-
sible predictors of RecAF: age, sex, structural heart disease, hypertension, persistent AF,
duration of AF (yrs), absence of right atrial flutter ablation, failure of > 3 class I/III antiar-
rhythmic drugs (AAD), left atrial enlargement, reduced left ventricular ejection fraction
(LVEF <50%), and elevated left atrial pressure.
Results The mean age was 54±10yrs and 120/147 pts (82%) were male. Structural
heart disease was present in 34%, hypertension in 37% and persistent AF in 20%. The
mean AF duration was 5.9±4.6yrs; right atrial flutter ablation was performed in 44%, and
28% had failed > 3 AAD. A reduced LVEF was present in 12%, and left atrial enlargement
in 37%. The mean left atrial pressure was 16±7mmHg. At 11.9±7.9 mths follow-up 101/
147pts (69%) were free from AF on no AADs. 19/147 (13%) had RecAF subsequently
controlled on AAD, and 27/147 (18%) had ongoing RecAF. Univariate predictors of
RecAF were a reduced LVEF (p=0.02) and longer AF duration (7.0 vs. 5.2yrs; p=0.04),
with a trend for male sex (p=0.07) and persistent AF (p=0.08). Multivariate predictors of
RecAF were a reduced LVEF (p=0.02; Odds Ratio 3.3), male sex (p=0.03; Odds Ratio
3.3) and longer AF duration (p=0.04; Odds Ratio 1.1).
Conclusion Following a single SPVI procedure a 31% rate of RecAF was observed in
this population. Male pts with reduced LVEF, longer AF duration, and possibly persistent
AF may require an alternative or additional catheter ablation strategy.
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828-3 Chronic Cure Rate After Pulmonary Vein Isolation in 
Patients With Nonparoxysmal Atrial Fibrillation: Impact 
of a Second Ablation
Mandeep Bhargava, Nassir F. Marrouche, David O. Martin, David Burkhardt, Yaariv 
Khaykin, George Joseph, Antonio Rossillo, Eduardo Saad, Robert A. Schweikert, Walid I. 
Saliba, Patrick J. Tchou, Andrea Natale, The Cleveland Clinic Foundation, Cleveland, OH
BACKGROUND: Pulmonary vein isolation (PVI) is mostly offered to patients with lone/
paroxysmal atrial fibrillation but its efficacy in non-paroxysmal AF is variable. We evalu-
ated the efficacy of PVI in non-paroxysmal AF compared to that in paroxysmal AF.
METHODS: 356 patients with symptomatic, drug refractory AF underwent PVI using a
uniform protocol. Group I included patients with paroxysmal AF (n=185) and Group II with
non-paroxysmal AF (n=171; 33 persistent and 138 permanent). Their baseline character-
istics are shown in Table 1. Patients followed-up for at least 6 months after their ablation
and in case of recurrence were offered a repeat procedure. The cure rate was analyzed
after the first and the second ablation, respectively. RESULTS: After a single ablation, 27/
185 patients with paroxysmal AF (14.6%) and 43/171 patients with non-paroxysmal AF
(25.1%) had recurrence of AF (p value 0.012). 21 patients in Group I and 38 patients in
Group II underwent a repeat procedure. The recurrence rates after the second procedure
were 5.4% and 7.1%, respectively (P value 0.52). CONCLUSIONS: The cure rate after a
single ablation is significantly lower in patients with non-paroxysmal AF (74.9% versus
85.4%; P<0.05). Freedom from AF after a repeat procedure was similar in both groups
(92.9% versus 94.6%; P=0.5). PV isolation can achieve comparable results in paroxys-
mal and non-paroxysmal AF. Patients with non-paroxysmal AF are more likely to require
a second procedure to achieve freedom from AF.
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828-4 Incremental Value of Isolating the Right Inferior 
Pulmonary Vein During Pulmonary Vein Isolation 
Procedures in Patients With Paroxysmal Atrial 
Fibrillation
Hakan Oral, Aman Chugh, Peter Cheung, Burr W. Hall, Srikar Veerareddy, Jihn Han, 
Kristina Lemola, Kamala Tamirisa, Frank Pelosi, Jr., Fred Morady, University of Michigan, 
Ann Arbor, MI
Background: Electrical isolation of the left superior, left inferior, and right superior pul-
monary veins is often, but not always, effective in eliminating paroxysmal atrial fibrillation
(PAF). The incremental clinical value of also isolating the right inferior pulmonary vein
during the first ablation session has not been well-defined.
Methods and Results: Pulmonary vein (PV) isolation by ostial applications of radiofre-
quency energy guided by PV potentials was performed in 176 consecutive patients
(mean age = 52 ± 11 years) with PAF. The left superior, left inferior, and right superior
PVs were targeted in 106 patients, and all 4 PVs were targeted 70 patients. Successful
isolation was achieved in 96% of targeted PVs. The mean duration of follow-up was 15 ±
7 months. At 1 year of follow-up, 58% of patients in whom 3 PVs were isolated were free
of recurrent PAF in the absence of antiarrhythmic drug therapy, compared to 73% of
patients in whom all 4 PVs were isolated (p=0.07).
Conclusions: There is a trend towards a better outcome when all 4 PVs are isolated
than when only the 3 major PVs are isolated. Whenever feasible, the right inferior pulmo-
nary vein should be isolated along with the other 3 PVs during the first ablation procedure
in patients with PAF.
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828-5 Definition of the Pulmonary Vein Ostia During Isolation 
Procedures: Comparison Between the CARTO 
Approach and Intracardiac Echo Guided Isolation
Yaariv Khaykin, Nassir Marrouche, Walid Saliba, Robert Schweikert, Eduardo Saad, 
David Burkhardt, Mandeep Bhargava, George Joseph, Antonio Rossillo, Andrea Natale, 
Cleveland Clinic Foundation, University Heights, OH
Ablation approaches for atrial fibrillation (AF) include pulmonary vein isolation (PVI)
guided using either the CARTO system or intracardiac echocardiography (ICE) and circu-
lar mapping. We reconstructed left atrial (LA) and PV anatomy using the CARTO system
in 6 consecutive patients. After generating the 3D structure of the LA and 24 PV with an
8mm tip catheter, tags were placed were lesions would be created based on the CARTO
guided approach. The operator was then blinded to the CARTO map and ablation lesions
were placed using circular mapping guided by ICE. Each lesion was tagged on the previ-
ously generated CARTO map. After completing PVI, the CARTO guided and ICE guided
ablation lines were compared. The CARTO guided ablation sites were on average 7.8
mm deeper in the PV. 68% of the CARTO guided ablation tags were deeper in the PV
than the corresponding ICE guided actual ablation tags. In 50% of the PV’s, CARTO PV
ostia were out of plane as compared to the PV ostia visualized using ICE. The table illus-
trates distances from ICE to CARTO guided ablation tags within each PV in mm by quad-
rant (Q1-4) starting at 12 o’clock. CONCLUSIONS: CARTO guided PVI results in
inadequate identification of the PV ostial plane and more distal lesion placement. This
difference could be responsible for the greater success and lower risk of PV stenosis with
CMC/ICE guided PVI.
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828-6 Structural Heart Disease Does Not Affect Outcomes of 
Pulmonary Vein Isolation for Treatment of Atrial 
Fibrillation
Yaariv Khaykin, Michael Chen, Nassir Marrouche, Walid Saliba, Robert Schweikert, 
David Burkhardt, Mandeep Bhargava, George Joseph, Antonio Rossillo, Eduardo Saad, 
Demet Erciyes, Andrea Natale, Cleveland Clinic Foundation, Cleveland, OH
Atrial fibrillation (AF) is the most common cardiac arrhythmia. It causes disability, impairs
quality of life, and is difficult to treat. Pulmonary vein isolation (PVI) to prevent initiation of
AF is becoming an accepted therapy for AF. Patients with structural heart disease (SHD)
are believed to differ from those with normal hearts (NHP) in the underlying pathophysiol-
ogy of their AF. This notion has deterred the application of PVI in the group most at risk
for AF. We prospectively followed 377 patients treated with PVI using intracardiac
echocardiography (ICE) guided circular mapping of the pulmonary vein ostia, 183 of
whom had SHD (left ventricular ejection fraction < 40%, significant aortic or mitral valve
disease (VD) and history of cardiac surgery (CVS)) for a mean of 15±7 months. Any AF
documented during this time period on predefined ambulatory monitoring protocol or
based on symptoms was considered a recurrence. The patients with VD and CVS were
older, had larger left atrial size, worse New York Heart Association functional class; more
of them had chronic AF. Total procedure and fluoroscopy time were longer only in low EF
Table 1
Character Group I Group II P value
Total patients 185 171 NS
Age 54.0 ± 11.8 55.5 ± 10.5 NS
Follow up (mths) 18.36 ± 6.08 18.11 ± 6.40 NS
Duration of AF (years) 6.4 ± 4.98 6.7 ± 5.4 NS
LA size (cms) 4.1 ± 0.56 4.5 ± 0.56 NS
LVEF (%) 54.7 ± 6.64 50.9 ± 9.4 NS
Hypertension/SHD 57/185 (31%) 110/171 (64%) P<0.05
Failed AADs 2.93 ± 1.13 3.13 ± 1.14 NS
Recurrence after 1st procedure 27/185 (14.6%) 43/171 (25.2%) 0.01
Recurrence after 2nd procedure 10/185 (5.4%) 12/171 (7.1%) 0.52
Q1 Q2 Q3 Q4 Average
RUPV 6.1 0.9 2.9 1.7 2.9
RLPV 9.3 8.7 6.3 9.7 8.5
LUPV 9.5 9.5 9.8 10.8 9.9
LLPV 14.0 9.9 8.3 7.5 9.9
